357
Views
4
CrossRef citations to date
0
Altmetric
Articles

Substance use history in behavioral-variant frontotemporal dementia versus primary progressive aphasia

, MD, FAPA, , PhD, , MD, , MD, , BA, BS & , PsyD

References

  • Whitehead NE, Trenz RC, Keen L 2nd, Rose J, Latimer WW. Younger versus older African Americans: patterns and prevalence of recent illicit drug use. J Ethn Subst Abuse 2014; 13(2):126–38.
  • Wu LT, Blazer DG. Substance use disorders and psychiatric comorbidity in mid and later life: a review. Int J Epidemiol 2014; 43(2):304–17.
  • Snyder M, Platt L. Substance use and brain reward mechanisms in older adults. J Psychosoc Nurs Ment Health Serv 2013; 51(7):15–20.
  • Kalapatapu RK, Sullivan MA. Prescription use disorders in older adults. Am J Addict 2010; 19(6):515–22.
  • Kalapatapu RK, Paris P, Neugroschl JA. Alcohol use disorders in geriatrics. Int J Psychiatry Med 2010; 40(3):321–37.
  • Rosen D, Engel RJ, Hunsaker AE, Engel Y, Detlefsen EG, Reynolds CF 3rd. Just say know: an examination of substance use disorders among older adults in gerontological and substance abuse journals. Soc Work Public Health 2013; 28(3–4):377–87.
  • Dowling GJ, Weiss SR, Condon TP. Drugs of abuse and the aging brain. Neuropsychopharmacology 2008; 33(2):209–18.
  • Kalapatapu RK, Lewis DF, Vinogradov S, Batki SL, Winhusen T. Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders. J Addict Dis 2013; 32(2):206–16.
  • Durazzo TC, Pennington DL, Schmidt TP, Mon A, Abe C, Meyerhoff DJ. Neurocognition in 1-month-abstinent treatment-seeking alcohol-dependent individuals: interactive effects of age and chronic cigarette smoking. Alcohol Clin Exp Res 2013; 37(10):1794–803.
  • Homer BD, Halkitis PN, Moeller RW, Solomon TM. Methamphetamine use and HIV in relation to social cognition. J Health Psychol 2013; 18(7):900–10.
  • Sofuoglu M, DeVito EE, Waters AJ, Carroll KM. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 2013; 64:452–63.
  • Wiers RW, Gladwin TE, Hofmann W, Salemink E, Ridderinkhof KR. Cognitive bias modification and cognitive control training in addiction and related psychopathology: mechanisms, clinical perspectives, and ways forward. Clin Psychol Sci 2013; 1(2):192–212.
  • Morgenstern J, Naqvi NH, Debellis R, Breiter HC. The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav 2013; 27(2):336–50.
  • Cadet JL, Bisagno V. The primacy of cognition in the manifestations of substance use disorders. Front Neurol 2013; 4:189.
  • Jentsch JD, Pennington ZT. Reward, interrupted: inhibitory control and its relevance to addictions. Neuropharmacology 2014; 76(Part B):479–86.
  • Herbeck DM, Brecht ML. Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine. J Addict Dis 2013; 32(1):11–25.
  • Kirshner HS. Frontotemporal dementia and primary progressive aphasia, a review. Neuropsychiatr Dis Treat 2014; 10:1045–55.
  • Miller JB, Banks SJ, Leger GC, Cummings JL. Randomized controlled trials in frontotemporal dementia: cognitive and behavioral outcomes. Transl Neurodegener 2014; 3:12.
  • Lima-Silva TB, Bahia VS, Nitrini R, Yassuda MS. Functional status in behavioral variant frontotemporal dementia: a systematic review. Biomed Res Int 2013; 2013:837120.
  • Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, Kramer JH. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev 2008; 18(1):91–102.
  • Caycedo AM, Miller B, Kramer J, Rascovsky K. Early features in frontotemporal dementia. Curr Alzheimer Res 2009; 6(4):337–40.
  • Warren JD, Rohrer JD, Rossor MN. Clinical review. Frontotemporal dementia. BMJ 2013; 347:f4827.
  • Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013; 25(2):130–7.
  • Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, Holton J, Revesz T, Kingsbury A, Morris HR, Burn DJ, Lees AJ. Hyposmia in progressive supranuclear palsy. Mov Disord 2010; 25(5):570–7.
  • Ibanez N. Atypical presentation of frontotemporal dementia masquerading as bipolar disorder and substance abuse: a case report. W V Med J 2012; 108(4):16–7.
  • Cruz M, Marinho V, Fontenelle LF, Engelhardt E, Laks J. Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia: case report. Cogn Behav Neurol 2008; 21(2):104–6.
  • Kalkonde YV, Jawaid A, Qureshi SU, Shirani P, Wheaton M, Pinto-Patarroyo GP, Schulz PE. Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimers Dement 2012; 8(3):204–10.
  • Chao SZ, Rosen HJ, Azor V, Ong H, Tse MM, Lai NB, Hou CE, Seeley WW, Miller BL, Matthews BR. Frontotemporal dementia in eight Chinese individuals. Neurocase 2012; 19(1):76–84.
  • Perry DC, Sturm VE, Seeley WW, Miller BL, Kramer JH, Rosen HJ. Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia. Brain 2014; 137(Pt 6):1621–6.
  • Grant JE, Chamberlain SR. Impulsive action and impulsive choice across substance and behavioral addictions: cause or consequence? Addict Behav 2014; 39(11):1632–9.
  • Hester R, Lubman D, Yücel M. The role of executive control in human drug addiction. In: Self DW, Staley Gottschalk JK, eds. Behavioral neuroscience of drug addiction. Heidelberg, Germany: Springer, 2010:301–18.
  • Blume AW, Marlatt GA. The role of executive cognitive functions in changing substance use: what we know and what we need to know. Ann Behav Med 2009; 37(2):117–25.
  • Sabodash V, Mendez MF, Fong S, Hsiao JJ. Suicidal behavior in dementia: a special risk in semantic dementia. Am J Alzheimers Dis Other Demen 2013; 28(6):592–9.
  • Chow TW, Links KA, Masterman DL, Mendez MF, Vinters HV. A case of semantic variant primary progressive aphasia with severe insular atrophy. Neurocase 2011; 18(6):450–6.
  • Rohrer JD, Rossor MN, Warren JD. Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis. Neurology 2010; 75(7):603–10.
  • Edwards-Lee T, Miller BL, Benson DF, Cummings JL, Russell GL, Boone K, Mena I. The temporal variant of frontotemporal dementia. Brain 1997; 120(Pt 6):1027–40.
  • NACC. National Alzheimer's Coordinating Center—Uniform Data Set. https://www.alz.washington.edu/WEB/study_pop.html (accessed January 15, 2015).
  • Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006; 20(4):210–6.
  • Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009; 23(2):91–101.
  • Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, Koepsell TD, Morris JC, Kukull WA, Centers NIAAsD. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord 2007; 21(3):249–58.
  • NACC. National Alzheimer's Coordinating Center—Uniform Data Set. IVP (Initial Visit Packet) Form. https://www.alz.washington.edu/NONMEMBER/UDS/DOCS/VER2/ivpfillable.pdf (accessed January 15, 2015).
  • NACC. National Alzheimer's Coordinating Center—Uniform Data Set. DV (Derived Variables) Form. https://www.alz.washington.edu/WEB/dervar.pdf (accessed January 15, 2015).
  • NACC. National Alzheimer's Coordinating Center—Uniform Data Set. UDS (Uniform Data Set) Forms and Documentation. https://www.alz.washington.edu/WEB/forms_uds.html (accessed January 15, 2015).
  • Rains VS, Ditzler TF. Alcohol use disorders in cognitively impaired patients referred for geriatric assessment. J Addict Dis 1993; 12(1):55–64.
  • Weintraub E, Weintraub D, Dixon L, Delahanty J, Gandhi D, Cohen A, Hirsch M. Geriatric patients on a substance abuse consultation service. Am J Geriatr Psychiatry 2002; 10(3):337–42.
  • Blow FC. Treatment of older women with alcohol problems: meeting the challenge for a special population. Alcohol Clin Exp Res 2000; 24(8):1257–66.
  • Blazer DG, Wu LT. The epidemiology of alcohol use disorders and subthreshold dependence in a middle-aged and elderly community sample. Am J Geriatr Psychiatry 2011; 19(8):685–94.
  • Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med 2014; 30(3):629–54.
  • Ward RA, Brier ME. Retrospective analyses of large medical databases: what do they tell us? J Am Soc Nephrol 1999; 10(2):429–32.
  • Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H. Retrospective economic and outcomes analyses using non-US databases: a review. Pharmacoeconomics 2007; 25(7):563–76.
  • Weinger MB, Slagle J, Jain S, Ordonez N. Retrospective data collection and analytical techniques for patient safety studies. J Biomed Inform 2003; 36(1–2):106–19.
  • Ho PM, Peterson PN, Masoudi FA. Evaluating the evidence: is there a rigid hierarchy? Circulation 2008; 118(16):1675–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.